Literature DB >> 455266

Blurring of vision: a previously undescribed complication of cyclophosphamide therapy.

G Kende, S R Sirkin, P R Thomas, A I Freeman.   

Abstract

Five children with cancer treated with high dose cyclophosphamide experienced blurring of vision. In three patients, the blurring lasted less than one hour and disappeared, abruptly, but in the other two, it was prolonged, lasting three and 14 days with gradual improvement. In all five complete restoration of normal vision occurred. We have not found other reports of this association in the literature.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 455266     DOI： 10.1002/1097-0142(197907)44:1<69::aid-cncr2820440113>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Immunosuppression in uveitis therapy.

Authors:  R N Van Gelder; H J Kaplan
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Blurring of vision due to ifosfamide.

Authors:  I A Choonara; M Overend; C C Bailey
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.

Authors:  R B Raffa; R J Tallarida
Journal:  J Clin Pharm Ther       Date:  2010-06       Impact factor: 2.512

4.  Identifying causal relationships of cancer treatment and long-term health effects among 5-year survivors of childhood cancer in Southern Sweden.

Authors:  Anders Holst; Jan Ekman; Magnus Petersson-Ahrholt; Thomas Relander; Thomas Wiebe; Helena M Linge
Journal:  Commun Med (Lond)       Date:  2022-03-02

Review 5.  Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.

Authors:  Carla C P Verstappen; Jan J Heimans; Klaas Hoekman; Tjeerd J Postma
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review.

Authors:  Ilias Georgalas; Theodore Paraskevopoulos; Chryssanthi Koutsandrea; Evgenia Kardara; Panagiotis Malamos; Dimitrios Ladas; Dimitris Papaconstantinou
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

Review 7.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.